Home > Healthcare > Medical Devices > Diagnostic Devices > Endomyocardial Biopsy Market

Endomyocardial Biopsy Market Share

Report ID: GMI6455
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Endomyocardial Biopsy Market Share

Some of the eminent industry participants operating in the endomyocardial biopsy market include :

Argon Medica Devices, Inc
Cordis
Mermaid Medical
Terumo Corporation
Scholten Surgical Instruments, Inc.
Changzhou Lookmed Medical Instrument Co., Ltd.
Medtronic plc
Boston Scientific Corporation
Teleflex Incorporated,
Cook Medical LLC
Merit Medical Systems

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market value for endomyocardial biopsy was USD 321.5 million in 2022 and is estimated to account for USD 619.2 million by 2032.

The hospital segment accounted for over 51% share in industry in 2022 and is anticipated to witness significant growth through 2032 as hospitals with active heart transplant programs require regular and thorough monitoring of transplant recipients to detect early signs of rejection.

U.S. market accounted for USD 109 million in 2022 and will witness substantial growth through 2032 attributable to the presence of highly advanced & well-established healthcare infrastructure with specialized cardiac centers and cutting-edge medical technologies.

Argon Medica Devices, Inc, Cordis, Mermaid Medical, Terumo Corporation, Scholten Surgical Instruments, Inc., Changzhou Lookmed Medical Instrument Co., Ltd., Medtronic plc, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC and Merit Medical Systems, Inc. among others.